Table 1.
Clinical findings in patients with myeloid sarcoma
| Case | Age, year/sex | Site | Bone marrow |
| 1 | 25/M | Scrotum | Uninvolved |
| 2 | 66/M | Kidney | RAEB-2* |
| 3 | 27/M | Testis | AML, M2 |
| 4 | 54/F | Colon | AML, M2 |
| 5 | 58/M | Orbit | Uninvolved |
| 6 | 72/M | Skin | Uninvolved |
| 7 | 46/F | Lymph Node | Uninvolved |
| 8 | 62/F | Gingiva | Myelofibrosis |
| 9 | 36/F | Vagina | AML, M1 |
| 10 | 38/M | T5, T7 | CML/BP** |
| 11 | 51/F | Gallbladder | AML, M5b |
| 12 | 40/F | Breast | AML, M1 |
| 13 | 38/F | Breast | AML, M4 |
*RAEB-2: Refractory anemia with excess blasts 2
**CML/BP: Chronic myelogeneous leukemia, blast phase